IDEA4RC FHIR Implementation Guide
1.0.0 - release
150
IDEA4RC FHIR Implementation Guide
1.0.0 - release
150
IDEA4RC FHIR Implementation Guide - Downloaded Version 1.0.0 See the Directory of published versions
| Active as of 2026-09-17 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="regimen-eu-i4rc"/>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet regimen-eu-i4rc</b></p><a name="regimen-eu-i4rc"> </a><a name="hcregimen-eu-i4rc"> </a><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <code>http://fhir.ohdsi.org/CodeSystem/concepts</code><span title="Version is not explicitly stated. No matching Code System found"> version Not Stated (use latest from terminology server)</span><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>35806965</td><td>Doxorubicin and Ifosfamide</td></tr><tr><td>35805248</td><td>Ifosfamide and Paclitaxel</td></tr><tr><td>35804228</td><td>Epirubicin monotherapy</td></tr><tr><td>35803691</td><td>Etoposide monotherapy</td></tr><tr><td>35804135</td><td>Gemcitabine monotherapy</td></tr><tr><td>35806435</td><td>Ifosfamide and Gemcitabine</td></tr><tr><td>35804542</td><td>Ifosfamide monotherapy</td></tr><tr><td>35805368</td><td>Irinotecan liposomal monotherapy</td></tr><tr><td>35805795</td><td>Lenvatinib monotherapy</td></tr><tr><td>35804095</td><td>Methotrexate monotherapy</td></tr><tr><td>35803677</td><td>Nivolumab monotherapy</td></tr><tr><td>35806821</td><td>ADT (other androgen deprivation therapy)</td></tr><tr><td>35805078</td><td>Oxaliplatin monotherapy</td></tr><tr><td>35804166</td><td>Paclitaxel monotherapy</td></tr><tr><td>35804158</td><td>Gemcitabine and Paclitaxel</td></tr><tr><td>35804201</td><td>Paclitaxel and Trastuzumab (TH)</td></tr><tr><td>35101452</td><td>Paclitaxel and Vinorelbine</td></tr><tr><td>35803678</td><td>Pembrolizumab monotherapy</td></tr><tr><td>35803487</td><td>Sorafenib monotherapy</td></tr><tr><td>35805230</td><td>Trastuzumab emtansine monotherapy (TDM1)</td></tr><tr><td>35804222</td><td>Trastuzumab monotherapy</td></tr><tr><td>35804241</td><td>Vinorelbine monotherapy</td></tr><tr><td>35806948</td><td>Epirubicin and Ifosfamide</td></tr><tr><td>35805452</td><td>Vincristine, Actinomycin D, Ifosfamide (VAI)</td></tr><tr><td>35803577</td><td>Docetaxel and Gemcitabine</td></tr><tr><td>35806964</td><td>Dacarbazine and Doxorubicin</td></tr><tr><td>35804819</td><td>Cisplatin and Doxorubicin</td></tr><tr><td>35805454</td><td>Ifosfamide and Etoposide (IE)</td></tr><tr><td>35806476</td><td>Cyclophosphamide and Etoposide</td></tr><tr><td>35806969</td><td>Dacarbazine and Gemcitabine</td></tr><tr><td>35805453</td><td>Cyclophosphamide and Topotecan</td></tr><tr><td>35805455</td><td>Irinotecan and Temozolomide</td></tr><tr><td>35804000</td><td>Busulfan and Melphalan</td></tr><tr><td>35805451</td><td>Vincristine, Ifosfamide, Doxorubicin, Etoposide (VIDE)</td></tr><tr><td>35805690</td><td>Pazopanib monotherapy</td></tr><tr><td>35804569</td><td>Regorafenib monotherapy</td></tr></table></li><li>Include these codes as defined in <a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html"><code>http://hl7.eu/fhir/ig/idea4rc/CodeSystem/cs-idea4rc-vocab-eu-i4rc</code></a><span title="Version is not explicitly stated, which means it is fixed to the version provided in this specification"> version 📦1.0.0</span><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100054">2000100054</a></td><td>doxorubicin and vincristine</td><td>doxorubicin and vincristine</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100055">2000100055</a></td><td>gemcitabine and vincristine</td><td>gemcitabine and vincristine</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100056">2000100056</a></td><td>high dose cisplatin</td><td>high dose cisplatin</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100057">2000100057</a></td><td>ifosfamide and etoposide</td><td>ifosfamide and etoposide</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100058">2000100058</a></td><td>weekly carboplatin</td><td>weekly carboplatin</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100059">2000100059</a></td><td>weekly cisplatin</td><td>weekly cisplatin</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100060">2000100060</a></td><td>Vincristine and Doxorubicin and Ifosfamide</td><td>Vincristine and Doxorubicin and Ifosfamide</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100061">2000100061</a></td><td>Methotrexate and Doxorubicin and Cisplatin</td><td>Methotrexate and Doxorubicin and Cisplatin</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100062">2000100062</a></td><td>Methotrexate and Doxorubicin and Ifosfamide</td><td>Methotrexate and Doxorubicin and Ifosfamide</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100063">2000100063</a></td><td>Doxorubicin and Cisplatin and Ifosfamide</td><td>Doxorubicin and Cisplatin and Ifosfamide</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100064">2000100064</a></td><td>Methotrexate and Vinorelbine</td><td>Methotrexate and Vinorelbine</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100065">2000100065</a></td><td>Vincristine and Doxorubicin and Cyclophosphamide</td><td>Vincristine and Doxorubicin and Cyclophosphamide</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100066">2000100066</a></td><td>Doxorubicin and Ifosfamide and Dacarbazine</td><td>Doxorubicin and Ifosfamide and Dacarbazine</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100067">2000100067</a></td><td>Irinotecan and Vincristine</td><td>Irinotecan and Vincristine</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100068">2000100068</a></td><td>TNF and Melphalan</td><td>TNF and Melphalan</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100069">2000100069</a></td><td>Cyclophosphamide and Vinorelbine</td><td>Cyclophosphamide and Vinorelbine</td></tr><tr><td><a href="CodeSystem-cs-idea4rc-vocab-eu-i4rc.html#cs-idea4rc-vocab-eu-i4rc-2000100070">2000100070</a></td><td>high dose Ifosfamide</td><td>high dose Ifosfamide</td></tr></table></li></ul></div>
</text>
<url value="http://hl7.eu/fhir/ig/idea4rc/ValueSet/regimen-eu-i4rc"/>
<version value="1.0.0"/>
<name value="RegimenVS"/>
<title value="Regimen"/>
<status value="active"/>
<experimental value="false"/>
<date value="2026-09-17T14:38:18+02:00"/>
<publisher value="IDEA4RC Project"/>
<contact>
<name value="IDEA4RC Project"/>
<telecom>
<system value="url"/>
<value value="https://www.idea4rc.eu/"/>
</telecom>
</contact>
<contact>
<name value="IDEA4RC Project"/>
<telecom>
<system value="url"/>
<value value="https://www.idea4rc.eu/"/>
</telecom>
</contact>
<description
value="This ValueSet includes a curated list of chemotherapy regimens used in oncologic treatment protocols."/>
<jurisdiction>
<coding>
<system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
<code value="150"/>
<display value="Europe"/>
</coding>
</jurisdiction>
<copyright
value="Copyright 2018 Odysseus Data Services, inc.
Licensed under the Apache License, Version 2.0 (the "License") you may not use this file except in compliance with the License.
You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0
Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an 'AS IS' BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.
See the License for the specific language governing permissions and limitations under the License. Company: Odysseus Data Services, Inc. Product Owner/Architecture: Gregory Klebanov Authors: Anastasiia Klochkova"/>
<compose>
<include>
<system value="http://fhir.ohdsi.org/CodeSystem/concepts"/>
<concept>
<code value="35806965"/>
<display value="Doxorubicin and Ifosfamide"/>
</concept>
<concept>
<code value="35805248"/>
<display value="Ifosfamide and Paclitaxel"/>
</concept>
<concept>
<code value="35804228"/>
<display value="Epirubicin monotherapy"/>
</concept>
<concept>
<code value="35803691"/>
<display value="Etoposide monotherapy"/>
</concept>
<concept>
<code value="35804135"/>
<display value="Gemcitabine monotherapy"/>
</concept>
<concept>
<code value="35806435"/>
<display value="Ifosfamide and Gemcitabine"/>
</concept>
<concept>
<code value="35804542"/>
<display value="Ifosfamide monotherapy"/>
</concept>
<concept>
<code value="35805368"/>
<display value="Irinotecan liposomal monotherapy"/>
</concept>
<concept>
<code value="35805795"/>
<display value="Lenvatinib monotherapy"/>
</concept>
<concept>
<code value="35804095"/>
<display value="Methotrexate monotherapy"/>
</concept>
<concept>
<code value="35803677"/>
<display value="Nivolumab monotherapy"/>
</concept>
<concept>
<code value="35806821"/>
<display value="ADT (other androgen deprivation therapy)"/>
</concept>
<concept>
<code value="35805078"/>
<display value="Oxaliplatin monotherapy"/>
</concept>
<concept>
<code value="35804166"/>
<display value="Paclitaxel monotherapy"/>
</concept>
<concept>
<code value="35804158"/>
<display value="Gemcitabine and Paclitaxel"/>
</concept>
<concept>
<code value="35804201"/>
<display value="Paclitaxel and Trastuzumab (TH)"/>
</concept>
<concept>
<code value="35101452"/>
<display value="Paclitaxel and Vinorelbine"/>
</concept>
<concept>
<code value="35803678"/>
<display value="Pembrolizumab monotherapy"/>
</concept>
<concept>
<code value="35803487"/>
<display value="Sorafenib monotherapy"/>
</concept>
<concept>
<code value="35805230"/>
<display value="Trastuzumab emtansine monotherapy (TDM1)"/>
</concept>
<concept>
<code value="35804222"/>
<display value="Trastuzumab monotherapy"/>
</concept>
<concept>
<code value="35804241"/>
<display value="Vinorelbine monotherapy"/>
</concept>
<concept>
<code value="35806948"/>
<display value="Epirubicin and Ifosfamide"/>
</concept>
<concept>
<code value="35805452"/>
<display value="Vincristine, Actinomycin D, Ifosfamide (VAI)"/>
</concept>
<concept>
<code value="35803577"/>
<display value="Docetaxel and Gemcitabine"/>
</concept>
<concept>
<code value="35806964"/>
<display value="Dacarbazine and Doxorubicin"/>
</concept>
<concept>
<code value="35804819"/>
<display value="Cisplatin and Doxorubicin"/>
</concept>
<concept>
<code value="35805454"/>
<display value="Ifosfamide and Etoposide (IE)"/>
</concept>
<concept>
<code value="35806476"/>
<display value="Cyclophosphamide and Etoposide"/>
</concept>
<concept>
<code value="35806969"/>
<display value="Dacarbazine and Gemcitabine"/>
</concept>
<concept>
<code value="35805453"/>
<display value="Cyclophosphamide and Topotecan"/>
</concept>
<concept>
<code value="35805455"/>
<display value="Irinotecan and Temozolomide"/>
</concept>
<concept>
<code value="35804000"/>
<display value="Busulfan and Melphalan"/>
</concept>
<concept>
<code value="35805451"/>
<display
value="Vincristine, Ifosfamide, Doxorubicin, Etoposide (VIDE)"/>
</concept>
<concept>
<code value="35805690"/>
<display value="Pazopanib monotherapy"/>
</concept>
<concept>
<code value="35804569"/>
<display value="Regorafenib monotherapy"/>
</concept>
</include>
<include>
<system
value="http://hl7.eu/fhir/ig/idea4rc/CodeSystem/cs-idea4rc-vocab-eu-i4rc"/>
<concept>
<code value="2000100054"/>
<display value="doxorubicin and vincristine"/>
</concept>
<concept>
<code value="2000100055"/>
<display value="gemcitabine and vincristine"/>
</concept>
<concept>
<code value="2000100056"/>
<display value="high dose cisplatin"/>
</concept>
<concept>
<code value="2000100057"/>
<display value="ifosfamide and etoposide"/>
</concept>
<concept>
<code value="2000100058"/>
<display value="weekly carboplatin"/>
</concept>
<concept>
<code value="2000100059"/>
<display value="weekly cisplatin"/>
</concept>
<concept>
<code value="2000100060"/>
<display value="Vincristine and Doxorubicin and Ifosfamide"/>
</concept>
<concept>
<code value="2000100061"/>
<display value="Methotrexate and Doxorubicin and Cisplatin"/>
</concept>
<concept>
<code value="2000100062"/>
<display value="Methotrexate and Doxorubicin and Ifosfamide"/>
</concept>
<concept>
<code value="2000100063"/>
<display value="Doxorubicin and Cisplatin and Ifosfamide"/>
</concept>
<concept>
<code value="2000100064"/>
<display value="Methotrexate and Vinorelbine"/>
</concept>
<concept>
<code value="2000100065"/>
<display value="Vincristine and Doxorubicin and Cyclophosphamide"/>
</concept>
<concept>
<code value="2000100066"/>
<display value="Doxorubicin and Ifosfamide and Dacarbazine"/>
</concept>
<concept>
<code value="2000100067"/>
<display value="Irinotecan and Vincristine"/>
</concept>
<concept>
<code value="2000100068"/>
<display value="TNF and Melphalan"/>
</concept>
<concept>
<code value="2000100069"/>
<display value="Cyclophosphamide and Vinorelbine"/>
</concept>
<concept>
<code value="2000100070"/>
<display value="high dose Ifosfamide"/>
</concept>
</include>
</compose>
</ValueSet>
IG © 2022+ IDEA4RC Project. Package hl7.eu.fhir.idea4rc#1.0.0 based on FHIR 4.0.1. Generated 2026-09-17
Links: Table of Contents |
QA Report
The IDEA4RC project has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 101057048.
